![Frank Neumann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Frank Neumann formerly worked at bluebird bio, Inc., as Vice President & Head-Oncology Clinical Research, Verastem, Inc., as Chief Medical Officer in 2021, and Kite Pharma, Inc., as Head-Clinical Development from 2021 to 2024.
Dr. Neumann received his doctorate degree from Heinrich-Heine-Universität Düsseldorf.
Ehemalige bekannte Positionen von Frank Neumann
| Unternehmen | Position | Ende |
|---|---|---|
| KITE PHARMA INC | Corporate Officer/Principal | 01.05.2024 |
| VERASTEM, INC. | Technik-/Wissenschafts-/F&E-Leiter | 20.01.2021 |
| GENETIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Frank Neumann
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
University of Bonn
 University of Bonn Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heinrich-Heine-Universität Düsseldorf
 Heinrich-Heine-Universität Düsseldorf Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
